How does high total cholesterol affect heart health?

High total cholesterol increases heart disease risk by contributing to plaque buildup in arteries, potentially leading to heart attacks and strokes. Managing cholesterol through diet, exercise, and regular monitoring can significantly reduce cardiovascular risks and improve long-term heart health.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Total Cholesterol and Its Components

Total cholesterol represents the sum of all cholesterol types circulating in your bloodstream. While often viewed negatively, cholesterol is actually essential for producing hormones, vitamin D, and substances that help digest food. Your liver produces about 80% of the cholesterol your body needs, with the remaining 20% coming from dietary sources.

Total cholesterol comprises several components, each playing different roles in cardiovascular health. Understanding these components helps explain why high total cholesterol poses risks to your heart. Regular monitoring through comprehensive lipid panels provides crucial insights into your cardiovascular health status.

The Four Main Components of Total Cholesterol

  • Low-Density Lipoprotein (LDL): Often called 'bad' cholesterol, LDL carries cholesterol from the liver to cells throughout the body. Excess LDL can accumulate in artery walls.
  • High-Density Lipoprotein (HDL): Known as 'good' cholesterol, HDL helps remove excess cholesterol from arteries and transport it back to the liver for disposal.
  • Very Low-Density Lipoprotein (VLDL): Primarily carries triglycerides and converts to LDL in the bloodstream.
  • Triglycerides: While technically fats rather than cholesterol, triglycerides are included in lipid panels and contribute to cardiovascular risk.

How High Cholesterol Damages Your Cardiovascular System

When total cholesterol levels remain elevated, particularly with high LDL and low HDL, a cascade of harmful processes begins in your blood vessels. This damage doesn't happen overnight but develops gradually over years or decades, often without noticeable symptoms until significant cardiovascular disease has developed.

Stages of Atherosclerotic Plaque Development

StageWhat HappensReversibilityClinical Impact
Fatty StreakFatty StreakLDL accumulates in artery wallsFully reversibleNo symptoms
Fibrous PlaqueFibrous PlaqueSmooth muscle cells form cap over lipid corePartially reversibleMay cause mild narrowing
Complicated PlaqueComplicated PlaquePlaque calcifies and may ruptureNot reversibleRisk of heart attack/stroke

Early intervention during reversible stages can prevent progression to dangerous complicated plaques.

The Atherosclerosis Process

Atherosclerosis, the primary way high cholesterol damages heart health, begins when excess LDL cholesterol penetrates the inner lining of artery walls. Once inside, LDL particles undergo oxidation, triggering an inflammatory response. White blood cells rush to the area, consuming the oxidized LDL and transforming into foam cells. These foam cells accumulate, forming fatty streaks that eventually develop into plaques.

As plaques grow, they narrow arteries and reduce blood flow to vital organs. More dangerously, plaques can rupture suddenly, causing blood clots that may completely block blood flow. When this occurs in coronary arteries, it causes a heart attack; in brain arteries, it results in a stroke. Understanding your cholesterol levels and their impact on plaque formation is essential for preventing these life-threatening events.

Beyond Plaque: Other Cardiovascular Effects

High cholesterol affects cardiovascular health through multiple mechanisms beyond plaque formation. It impairs endothelial function, reducing blood vessels' ability to dilate properly. This dysfunction contributes to high blood pressure and reduces oxygen delivery to tissues. Additionally, high cholesterol promotes inflammation throughout the cardiovascular system, creating a pro-thrombotic state that increases clot formation risk.

Risk Factors and Warning Signs

High cholesterol typically develops silently, earning it the nickname 'silent killer.' Most people discover elevated levels only through blood tests, as the condition rarely causes noticeable symptoms until significant cardiovascular damage has occurred. However, certain risk factors significantly increase your likelihood of developing high cholesterol.

Major Risk Factors for High Cholesterol

  • Diet high in saturated and trans fats
  • Sedentary lifestyle with minimal physical activity
  • Obesity, particularly abdominal obesity
  • Smoking, which damages blood vessels and lowers HDL
  • Diabetes, which often accompanies lipid abnormalities
  • Family history of high cholesterol or early heart disease
  • Age (risk increases for men after 45 and women after 55)
  • Certain medications, including steroids and some blood pressure drugs

While high cholesterol itself rarely causes symptoms, extremely elevated levels may produce visible signs. Xanthomas (yellowish cholesterol deposits under the skin) and corneal arcus (gray-white rings around the cornea) can indicate familial hypercholesterolemia, a genetic condition causing very high cholesterol from birth.

Optimal Cholesterol Levels for Heart Health

Understanding optimal cholesterol ranges helps you assess your cardiovascular risk and set appropriate health goals. While guidelines provide general targets, individual risk factors influence what levels are ideal for you. Recent research emphasizes the importance of looking beyond total cholesterol to specific components and ratios.

The total cholesterol to HDL ratio provides valuable risk assessment information. A ratio below 3.5:1 is considered optimal, while ratios above 5:1 indicate increased cardiovascular risk. Similarly, the triglyceride to HDL ratio offers insights into insulin resistance and metabolic health, with ratios below 2:1 being ideal.

Advanced Testing: Beyond Basic Cholesterol Panels

While standard lipid panels provide valuable information, advanced testing offers deeper insights into cardiovascular risk. Apolipoprotein B (ApoB) testing measures the number of atherogenic particles in your blood, providing a more accurate risk assessment than LDL cholesterol alone. Since each LDL, VLDL, and IDL particle contains one ApoB molecule, this test effectively counts all potentially harmful cholesterol-carrying particles.

Research shows ApoB levels predict cardiovascular events more accurately than traditional cholesterol measurements. Optimal ApoB levels are below 90 mg/dL, with levels above 130 mg/dL indicating high risk. For comprehensive cardiovascular assessment, consider testing that includes both traditional markers and advanced biomarkers like ApoB and ApoA1.

Lipoprotein(a): The Genetic Risk Factor

Lipoprotein(a), or Lp(a), represents a genetically determined risk factor that standard cholesterol tests miss. Elevated Lp(a) independently increases cardiovascular disease risk, regardless of other cholesterol levels. Since Lp(a) levels remain relatively stable throughout life and don't respond well to lifestyle changes, identifying elevated levels helps determine if more aggressive management of other risk factors is necessary.

Natural Strategies to Improve Cholesterol Levels

Lifestyle modifications can significantly impact cholesterol levels and cardiovascular health. Many people successfully manage their cholesterol through dietary changes, exercise, and other natural approaches before requiring medication. These strategies not only improve cholesterol profiles but enhance overall metabolic health.

Dietary Approaches for Cholesterol Management

The Mediterranean diet pattern consistently demonstrates powerful cholesterol-lowering effects. This approach emphasizes whole grains, fruits, vegetables, legumes, nuts, and olive oil while limiting red meat and processed foods. Studies show this dietary pattern can reduce LDL cholesterol by 10-15% while increasing protective HDL levels.

  • Increase soluble fiber intake from oats, beans, apples, and psyllium
  • Replace saturated fats with monounsaturated fats from olive oil and avocados
  • Include fatty fish rich in omega-3s at least twice weekly
  • Add plant sterols and stanols from fortified foods or supplements
  • Limit dietary cholesterol from egg yolks and organ meats
  • Eliminate trans fats found in processed and fried foods

Exercise and Physical Activity Benefits

Regular physical activity improves cholesterol profiles through multiple mechanisms. Aerobic exercise increases HDL cholesterol while reducing triglycerides and small, dense LDL particles. Resistance training complements aerobic exercise by improving insulin sensitivity and metabolic health. Aim for at least 150 minutes of moderate-intensity exercise weekly, combining both aerobic and strength training activities.

When Lifestyle Changes Aren't Enough

Despite committed lifestyle modifications, some individuals require medication to achieve optimal cholesterol levels. This need doesn't represent failure but rather reflects genetic factors, underlying conditions, or the severity of cardiovascular risk. Modern cholesterol-lowering medications are generally safe and effective when properly monitored.

Statins remain the first-line medication for most people with high cholesterol, reducing LDL by 30-50% and significantly lowering cardiovascular event risk. For those unable to tolerate statins or needing additional LDL reduction, alternatives include ezetimibe, PCSK9 inhibitors, and bempedoic acid. Regular monitoring ensures medication effectiveness while identifying any potential side effects early.

Taking Control of Your Heart Health

High total cholesterol significantly impacts heart health, but understanding this relationship empowers you to take protective action. Through regular testing, you can identify problems early when they're most treatable. Combining comprehensive biomarker assessment with lifestyle modifications provides the best strategy for maintaining optimal cardiovascular health throughout life.

Remember that cholesterol management is a marathon, not a sprint. Small, sustainable changes often produce better long-term results than drastic short-term efforts. Work with healthcare providers to develop a personalized approach based on your unique risk factors, preferences, and goals. With proper monitoring and management, you can significantly reduce your cardiovascular disease risk and enjoy better health for years to come.

References

  1. Ference, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., ... & Catapano, A. L. (2017). Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. European Heart Journal, 38(32), 2459-2472.[Link][DOI]
  2. Sniderman, A. D., Thanassoulis, G., Glavinovic, T., Navar, A. M., Pencina, M., Catapano, A., & Ference, B. A. (2019). Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiology, 4(12), 1287-1295.[Link][DOI]
  3. Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., ... & Ziaeian, B. (2019). 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation, 140(11), e596-e646.[Link][DOI]
  4. Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M. I., Corella, D., Arós, F., ... & Martínez-González, M. A. (2018). Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. New England Journal of Medicine, 378(25), e34.[Link][DOI]
  5. Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., ... & Wiklund, O. (2020). 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal, 41(1), 111-188.[Link][DOI]
  6. Toth, P. P., Barter, P. J., Rosenson, R. S., Boden, W. E., Chapman, M. J., Cuchel, M., ... & Moriarty, P. M. (2018). High-density lipoproteins: a consensus statement from the National Lipid Association. Journal of Clinical Lipidology, 12(5), 1077-1099.[Link][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my total cholesterol at home?

You can test your total cholesterol at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive cholesterol testing along with other cardiovascular biomarkers. The program provides CLIA-certified lab results from a simple at-home blood draw.

What is considered a dangerous total cholesterol level?

Total cholesterol above 240 mg/dL is considered high risk, while levels between 200-239 mg/dL are borderline high. However, the distribution between HDL and LDL cholesterol matters more than the total number. Very high levels above 300 mg/dL require immediate medical attention.

How quickly can I lower my cholesterol naturally?

With dedicated lifestyle changes, you can see cholesterol improvements within 6-8 weeks. Dietary modifications typically show results faster than exercise alone. Most people experience a 10-20% reduction in LDL cholesterol through lifestyle changes, though individual results vary based on genetics and baseline levels.

Does high cholesterol always require medication?

Not always. Many people successfully manage cholesterol through diet, exercise, and lifestyle modifications. The decision to use medication depends on your overall cardiovascular risk, including factors like age, blood pressure, smoking status, and family history. Your healthcare provider can help determine the best approach for your situation.

Can you have high cholesterol without any symptoms?

Yes, high cholesterol typically causes no symptoms, which is why it's called a 'silent' condition. Most people only discover elevated levels through blood tests. In rare cases of extremely high cholesterol, visible signs like xanthomas (fatty deposits under the skin) may appear, but these are uncommon.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details